1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients. - Pi, J.; He, X.; Zhou, S.; Liu, P.; Yang, J.; Wei, G.; Wang, T.; Jin, J.; Lin, Y.; Lv, Q.; Zhang, W. (Annals of Oncology, 2025)